
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma
Xingyu Chang, Zhanjun Ma, Guomao Zhu, et al.
Journal of bone oncology (2021) Vol. 29, pp. 100372-100372
Open Access | Times Cited: 54
Xingyu Chang, Zhanjun Ma, Guomao Zhu, et al.
Journal of bone oncology (2021) Vol. 29, pp. 100372-100372
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications
Tianyi Zhu, Jing Han, Yang Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Tianyi Zhu, Jing Han, Yang Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Advances in Osteosarcoma
Isidora Panez-Toro, Javier Muñoz-García, Jorge William Vargas-Franco, et al.
Current Osteoporosis Reports (2023) Vol. 21, Iss. 4, pp. 330-343
Open Access | Times Cited: 71
Isidora Panez-Toro, Javier Muñoz-García, Jorge William Vargas-Franco, et al.
Current Osteoporosis Reports (2023) Vol. 21, Iss. 4, pp. 330-343
Open Access | Times Cited: 71
Advances on immunotherapy for osteosarcoma
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential
Wen Yang, Fan Tang, Chongqi Tu, et al.
Cancer Letters (2022) Vol. 547, pp. 215887-215887
Closed Access | Times Cited: 58
Wen Yang, Fan Tang, Chongqi Tu, et al.
Cancer Letters (2022) Vol. 547, pp. 215887-215887
Closed Access | Times Cited: 58
Effects of BMSC-Derived EVs on Bone Metabolism
Xuchang Zhou, Hong Cao, Jianming Guo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1012-1012
Open Access | Times Cited: 52
Xuchang Zhou, Hong Cao, Jianming Guo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1012-1012
Open Access | Times Cited: 52
Novel Immunotherapies for Osteosarcoma
Yubao Lu, Jiahe Zhang, Yutong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 45
Yubao Lu, Jiahe Zhang, Yutong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 45
Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials
Consolato Sergi, Mervin Burnett, Eugeniu Jantuan, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 664-664
Open Access | Times Cited: 1
Consolato Sergi, Mervin Burnett, Eugeniu Jantuan, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 664-664
Open Access | Times Cited: 1
Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy
Virinder Kaur Sarhadi, Ravindra Daddali, Riitta Seppänen‐Kaijansinkko
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11035-11035
Open Access | Times Cited: 48
Virinder Kaur Sarhadi, Ravindra Daddali, Riitta Seppänen‐Kaijansinkko
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11035-11035
Open Access | Times Cited: 48
Application of mesenchymal stem cell exosomes in the treatment of skin wounds
Xinyu Zhao, Wei Zhang, Junjuan Fan, et al.
Smart Materials in Medicine (2023) Vol. 4, pp. 578-589
Open Access | Times Cited: 17
Xinyu Zhao, Wei Zhang, Junjuan Fan, et al.
Smart Materials in Medicine (2023) Vol. 4, pp. 578-589
Open Access | Times Cited: 17
Exosomal microRNA⁃93⁃3p secreted by bone marrow mesenchymal stem cells downregulates apoptotic peptidase activating factor 1 to promote wound healing
Caiqi Shen, Changbo Tao, Aijun Zhang, et al.
Bioengineered (2021) Vol. 13, Iss. 1, pp. 27-37
Open Access | Times Cited: 35
Caiqi Shen, Changbo Tao, Aijun Zhang, et al.
Bioengineered (2021) Vol. 13, Iss. 1, pp. 27-37
Open Access | Times Cited: 35
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 16
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 16
Exosomes Derived from Dental Pulp Stem Cells Show Different Angiogenic and Osteogenic Properties in Relation to the Age of the Donor
Giulia Brunello, Federica Zanotti, Martina Trentini, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 908-908
Open Access | Times Cited: 22
Giulia Brunello, Federica Zanotti, Martina Trentini, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 908-908
Open Access | Times Cited: 22
The interaction between osteosarcoma and other cells in the bone microenvironment: From mechanism to clinical applications
Jin Zeng, Yi Peng, Dong Wang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 12
Jin Zeng, Yi Peng, Dong Wang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 12
Advances in the Study of Exosomes as Drug Delivery Systems for Bone-Related Diseases
Jiawen Huang, Yang Xu, Yuxuan Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 220-220
Open Access | Times Cited: 11
Jiawen Huang, Yang Xu, Yuxuan Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 220-220
Open Access | Times Cited: 11
Chorioallantoic Membrane Assay at the Cross-Roads of Adipose-Tissue-Derived Stem Cell Research
Dmytro Oliinyk, Andreas Eigenberger, Oliver Felthaus, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 592-592
Open Access | Times Cited: 11
Dmytro Oliinyk, Andreas Eigenberger, Oliver Felthaus, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 592-592
Open Access | Times Cited: 11
NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance
Shaoyan Shi, Xuehai Ou, Chao Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Shaoyan Shi, Xuehai Ou, Chao Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Different exosomes are loaded in hydrogels for the application in the field of tissue repair
Yanyan Zhang, Wenjing Yan, Le Wu, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Yanyan Zhang, Wenjing Yan, Le Wu, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Targeting B4GALT3 in BMSCs-EVs for Therapeutic Control of HCC via NF-κB pathway inhibition
Juncheng Guo, Kaiqiong Wang, Qigang Sun, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Juncheng Guo, Kaiqiong Wang, Qigang Sun, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Advances in cell therapy for orthopedic diseases: bridging immune modulation and regeneration
Jing Wang, Shenghao Xu, Bo Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jing Wang, Shenghao Xu, Bo Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Osteoblast-derived exosomes promote osteogenic differentiation of osteosarcoma cells via URG4/Wnt signaling pathway
Y.G. Leng, Jingtang Li, Zhisheng Long, et al.
Bone (2023) Vol. 178, pp. 116933-116933
Closed Access | Times Cited: 10
Y.G. Leng, Jingtang Li, Zhisheng Long, et al.
Bone (2023) Vol. 178, pp. 116933-116933
Closed Access | Times Cited: 10
Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma
Renxuan Huang, Mingxian Xu, Weitang Guo, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Renxuan Huang, Mingxian Xu, Weitang Guo, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Hsa_circ_0073453 modulates IL-8 secretion by GC-MSCs to promote gastric cancer progression by sponging miR-146a-5p
Chen Wu, Xiaoli Cao, Juan Xu, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110121-110121
Closed Access | Times Cited: 8
Chen Wu, Xiaoli Cao, Juan Xu, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110121-110121
Closed Access | Times Cited: 8
BMSC-EV-derived lncRNA NORAD Facilitates Migration, Invasion, and Angiogenesis in Osteosarcoma Cells by Regulating CREBBP via Delivery of miR-877-3p
Dapeng Feng, Zhengwei Li, Liang Yang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 14
Dapeng Feng, Zhengwei Li, Liang Yang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 14